Accumulation of cardiolipin and lysocardiolipin in fibroblasts from Tangier disease subjects

被引:29
作者
Fobker, M
Voss, R
Reinecke, H
Crone, C
Assmann, G
Walter, M
机构
[1] Univ Munster, Inst Phys, D-4400 Munster, Germany
[2] Univ Munster, Inst Med C, D-4400 Munster, Germany
[3] Univ Munster, Inst Arterioskleroseforsch, D-4400 Munster, Germany
[4] Univ Munster, Inst Klin Chem & Lab Med, D-4400 Munster, Germany
关键词
Tangier disease; high density lipoprotein; familial high density lipoprotein deficiency; apolipoprotein A-1; ATP binding cassette transporter 1; cardiolipin; lysocardiolipin; Niemann-Pick type C disease; sterol trafficking;
D O I
10.1016/S0014-5793(01)02578-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tangier disease (TD) is an inherited disorder of lipid metabolism characterized by very low high density lipoprotein (HDL) plasma levels, cellular cholesteryl ester accumulation and reduced cholesterol excretion in response to HDL apolipoproteins, Molecular defects in the ATP binding cassette transporter 1 (ABCA1) have recently been identified as the cause of TD. ASCA1 plays a key role in the translocation of cholesterol across the plasma membrane, and defective ABCA1 causes cholesterol storage in TD cells, Not only cholesterol efflux, but also phospholipid efflux was shown to be impaired in TD cells. By use of thin layer chromatography, high performance liquid chromatography and time-of-flight secondary ion mass spectrometry, we characterized the cellular phospholipid content in fibroblasts from three homozygous TD patients. The cellular content of the major phospholipids was not found to be significantly altered in TD fibroblasts, However, the two phospholipids cardiolipin and lysocardiolipin, which make up minute amounts in normal cells, were at least 3-5-fold enriched in fibroblasts from TD subjects. A structurally closely related phospholipid (lysobisphosphatidic acid) has recently been shown to be enriched in Niemann-Pick type C. another lipid storage disorder, Altogether these data may indicate that the role of these phospholipids is a regulatory one rather than that of a bulk mediator of cholesterol solubilization in sterol trafficking and efflux. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 41 条
[1]   CHARACTERIZATION OF HIGH-DENSITY LIPOPROTEINS IN PATIENTS HETEROZYGOUS FOR TANGIER DISEASE [J].
ASSMANN, G ;
SIMANTKE, O ;
SCHAEFER, HE ;
SMOOTZ, E .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (05) :1025-1035
[2]  
ASSMANN G, 1998, METABOLIC BASIS INHE, P2053
[3]   SURFACE MS - PROBING REAL-WORLD SAMPLES [J].
BENNINGHOVEN, A ;
HAGENHOFF, B ;
NIEHUIS, E .
ANALYTICAL CHEMISTRY, 1993, 65 (14) :A630-A640
[4]   Removal of cholesterol from extrahepatic sources by oxidative mechanisms [J].
Björkhem, I ;
Diczfalusy, U ;
Lütjohann, D .
CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (02) :161-165
[5]   ATHEROSCLEROSIS AND STEROL 27-HYDROXYLASE - EVIDENCE FOR A ROLE OF THIS ENZYME IN ELIMINATION OF CHOLESTEROL FROM HUMAN MACROPHAGES [J].
BJORKHEM, I ;
ANDERSSON, O ;
DICZFALUSY, U ;
SEVASTIK, B ;
XIU, RJ ;
DUAN, CG ;
LUND, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) :8592-8596
[6]   The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency [J].
Brooks-Wilson, A ;
Marcil, M ;
Clee, SM ;
Zhang, LH ;
Roomp, K ;
van Dam, M ;
Yu, L ;
Brewer, C ;
Collins, JA ;
Molhuizen, HOF ;
Loubser, O ;
Ouelette, BFF ;
Fichter, K ;
Ashbourne-Excoffon, KJD ;
Sensen, CW ;
Scherer, S ;
Mott, S ;
Denis, M ;
Martindale, D ;
Frohlich, J ;
Morgan, K ;
Koop, B ;
Pimstone, S ;
Kastelein, JJP ;
Genest, J ;
Hayden, MR .
NATURE GENETICS, 1999, 22 (04) :336-345
[9]   Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis [J].
Carstea, ED ;
Morris, JA ;
Coleman, KG ;
Loftus, SK ;
Zhang, D ;
Cummings, C ;
Gu, J ;
Rosenfeld, MA ;
Pavan, WJ ;
Krizman, DB ;
Nagle, J ;
Polymeropoulos, MH ;
Sturley, SL ;
Ioannou, YA ;
Higgins, ME ;
Comly, M ;
Cooney, A ;
Brown, A ;
Kaneski, CR ;
BlanchetteMackie, EJ ;
Dwyer, NK ;
Neufeld, EB ;
Chang, TY ;
Liscum, L ;
Strauss, JF ;
Ohno, K ;
Zeigler, M ;
Carmi, R ;
Sokol, J ;
Markie, D ;
ONeill, RR ;
vanDiggelen, OP ;
Elleder, M ;
Patterson, MC ;
Brady, RO ;
Vanier, MT ;
Pentchev, PG ;
Tagle, DA .
SCIENCE, 1997, 277 (5323) :228-231
[10]   Fate of endogenously synthesized cholesterol in Niemann-Pick type C1 cells [J].
Cruz, JC ;
Chang, TY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) :41309-41316